Hip Arthritis and Labral Tear Treatment in Santa Barbara

Candidacy is determined through a formal assessment, not assumed. The best candidates are generally patients with moderate joint degeneration or soft tissue injury who have not found lasting relief from physical therapy, NSAIDs, or cortisone injections, and who want to pursue a regenerative approach before considering surgery. Patients with bone-on-bone arthritis in all joint compartments, significant structural deformity, or other complicating factors may have more limited potential benefit, though this is evaluated on an individual basis. Dr. Scheinberg will give you a straight answer about whether you are a likely responder.

The number of treatments depends on the condition being addressed, its severity, and how your body responds. For soft tissue injuries such as tendinopathy or partial ligament tears, one to two PRP sessions is often sufficient. For knee or hip arthritis, a series of two to three injections spaced several weeks apart is typically recommended. For more advanced joint degeneration treated with BMAC or the combined approach, a single comprehensive treatment session is often the starting point, with follow-up assessment at 12 weeks to evaluate response. Dr. Scheinberg will not recommend additional treatments unless the clinical picture supports them.

Orthobiologic treatments using PRP and BMAC carry a low risk profile because they use materials derived from your own body. The most common side effects are temporary soreness, swelling, or stiffness at the injection site, which typically resolve within a few days. There is a small risk of infection with any injection, which is minimized by the clinic's use of sterile technique and surgical-grade standards. For patients on blood thinners or with certain medical conditions, Dr. Scheinberg will assess these factors as part of the consultation. The treatment is not appropriate for patients with active infection, certain clotting disorders, or active malignancy.